EANS-Adhoc: - Marseille-Kliniken AG appoints new member to Management Board

--------------------------------------------------------------------------------
ad-hoc disclosure pursuant to section 15 of the WpHG transmitted by euro
adhoc with the aim of a Europe-wide distribution. The issuer is solely
responsible for the content of this announcement.
--------------------------------------------------------------------------------

11.06.2010

Berlin, 11 June 2010. Marseille-Kliniken AG (Prime Standard, ISIN DE 0007783003,
MKA) has appointed Dr. Thomas Klaue (52) to the Management Board effective
1 July 2010. He is undertaking the role of the Chief Financial Officer (CFO) and
has also been appointed the Vice Chairman of the Management Board. This was
resolved unanimously by the Supervisory Board in its meeting yesterday. The
Management Board contract of Dr. Klaue has a term of three years.

Until April 2010, Dr. Klaue served as the CFO of MediGene AG, one of the leading
German biotech companies based in Martinsried. Prior to that position, he worked
in a number of executive roles at Infineon AG and Dasa.

Dr. Klaue is succeeding Claus Dobrowolski (53), who took over the role of
interim CFO in April 2010. The Supervisory Board would like to thank Claus
Dobrowolski for his valuable support.

End of ad hoc release

Further inquiry note:
Hillermann Consulting
Christian Hillermann
Investor Relations for Marseille-Kliniken AG
Poststraße 14/16
20354 Hamburg
Germany
Tel.: +49-(0)40 / 320 279-10
Fax: +49-(0)40 / 320 279-114
www.hillermann-consulting.de

Marseille-Kliniken AG
Dr. Ute Buchheim
Friedrich-Ebert-Str. 65
33330 Gütersloh
Germany
Tel.: +49-(0)5241 / 90 39-35
Fax: +49-(0)5241 / 90 39-39
www.marseille-kliniken.com
end of announcement euro adhoc
--------------------------------------------------------------------------------

issuer:   Marseille-Kliniken AG
          Alte Jakobstraße 79/80
          D-10709 Berlin
phone:    +49 (0)30 246 32-400 
FAX:      +49 (0)30 246 32-401
mail:     [email protected]
WWW:      http://www.marseille-kliniken.de
sector:   Pharmaceuticals

ISIN: DE0007783003
indexes: CDAX, Classic All Share, Prime All Share
stockmarkets: regulated dealing/prime standard: Frankfurt, free trade: Berlin,
Stuttgart, Düsseldorf, regulated dealing: Hamburg
language: English

OTS-ORIGINALTEXT PRESSEAUSSENDUNG UNTER AUSSCHLIESSLICHER INHALTLICHER VERANTWORTUNG DES AUSSENDERS - WWW.OTS.AT | OTB

print